MedPath
FDA Approval

Naproxen

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
July 18, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Naproxen(500 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Quality Care Products, LLC

Quality Care Products, LLC

831276758

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Naproxen

Product Details

NDC Product Code
55700-888
Application Number
ANDA212517
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
March 18, 2021
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRTClass: IACT
NaproxenActive
Code: 57Y76R9ATQClass: ACTIBQuantity: 500 mg in 1 1
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94EClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
© Copyright 2025. All Rights Reserved by MedPath